A week into his tenure as head of the FDA’s Center for Drug Evaluation and Research, experts agree that Rick Pazdur is the “ideal fit” to stabilize the agency. And, according to one ex-FDA official, ...
The FDA on Nov. 11 appointed Richard Pazdur, MD, as the new director of the Center for Drug Evaluation and Research.Pazdur ...
The FDA has appointed one of its most respected cancer drug regulators to lead the agency’s main division for approving new drugs.
The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on ...
Clinical Trials Arena on MSN
FDA’s revolving door reveals Pazdur as new CDER head
"FDA’s revolving door reveals Pazdur as new CDER head" was originally created and published by Clinical Trials Arena, a ...
The FDA on Tuesday announced 26-year agency veteran Richard Pazdur will replace a top regulator who resigned earlier this month amid accusations of abusing his power. Pazdur will be the director of ...
In reaching within to name 26-year FDA veteran Richard Pazdur as the next CDER director, FDA Commissioner Marty Makary likely chose the best possible person to helm the drug evaluation center at a ...
Pharma Pulse: FDA Appoints Richard Pazdur as CDER Director Amid 340B Tensions and Novartis Expansion
This episode of Pharma Pulse discusses how Dr. Richard Pazdur’s appointment signals a new era for FDA drug evaluation, why hospitals are opposing the government’s 340B pilot program, and how Novartis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback